Field Trip Announces the Launch of Freedom by Field Trip™, a First-of-Its-Kind Ketamine Therapy Program

The One Year Wellness Journey Blends Field Trip’s Proven Ketamine-Assisted Therapies with a Holistic Membership Program to Help People Heal and Make Lasting Change

TORONTO, Nov. 15, 2022 (GLOBE NEWSWIRE) -- Field Trip Health & Wellness Ltd. (TSX-V: FTHW) ("Field Trip" or the “Company”), a global leader in the delivery of psychedelic therapies, today launched Freedom by Field Trip™ (the “Program”), a first-of-its-kind one-year hybrid ketamine therapy program that blends the power of psychedelic-assisted therapies with holistic wellness support such as meditations, nutrition classes, integration therapy, breathwork, somatic movement therapy, community talks, and membership events. The Program, which offers people the ability to participate in ketamine therapy at-home or in one of Field Trip’s locations, is designed to increase accessibility to psychedelic-assisted therapy for those suffering from mild to moderate depression, anxiety, and trauma and support it with a holistic approach to mental health and well-being.

“When you live in a world where a quarter of your community will experience depression, yet antidepressants perform no better than placebo in 85 percent of cases1, we don’t just need new medicines, we need a whole new approach to mental health,” said Ronan Levy, Chairman and CEO of Field Trip. “With our current immersive in-person ketamine-assisted therapies, 93 percent of our clients experience noticeable improvement immediately after treatment, and the majority of clients sustain their progress for more than four months. This led us to launch Freedom by Field Trip™, which enables us to expand beyond our physical footprint and amplify the power of our therapies with flexibility, accessibility and a truly holistic approach to healing.”

The Program provides up to 12 at-home or in-person ketamine exploration dosing sessions per year, medical supervision to customize the ketamine explorations and one-on-one integration therapy sessions as well as unlimited group integration sessions with licensed therapists.

Uniquely, the Program is divided into three “chapters” that are intentionally delivered on a week-by-week basis to optimize the effects of the ketamine, enhance neuroplasticity (the brain’s ability to heal and form new neural connections) and improve mental wellness:

  • Chapter 1: Awaken - in months 1-3, clients follow Field Trip’s evidence-based ketamine-assisted therapy protocol and begin with six low-dose ketamine explorations designed to prompt introspective thinking and remove mental obstacles, supported by integration therapy, journaling, meditation, and wellness classes.
  • Chapter 2: Strengthen: in months 4-6, through continued classes, one-on-one therapy, group integration circles, and daily practice, clients will create and strengthen healthier thought patterns and experience an increase in neuroplasticity.
  • Chapter 3: Deepen: in months 7 - 12, clients will continue weekly wellness programming and, subject to medical approval, complete six additional ketamine explorations to enhance personal growth, extend the results of treatment, and solidify the progress that has been made.

Freedom by Field Trip™ redefines how we think about treating depression, anxiety, trauma and other mental health conditions. It not only democratizes access to psychedelic therapies by providing flexibility of location and an affordable monthly membership-based fee structure, it also breaks down the walls between different healing modalities and unites them in a single program,” added Dr. Monique Moller, a practicing physician at Field Trip and the Company's Vice President of Integrated Health. “While there is no magic bullet for mental health, this is the kind of innovation the world needs: the power of psychedelic therapies combined with other healing modalities, all with significantly fewer barriers. It gives people the freedom to access deeper, more complete healing so they can live their lives free of depression, anxiety and trauma.”

Freedom by Field Trip™ will initially be available in California and Washington State and the Company expects to rollout to additional jurisdictions in 2023. At launch, the monthly fee for the Program will be $299.

For more information, visit

About Field Trip Health & Wellness Ltd.

With a large global community of psychedelic-interested people, proprietary psychedelic therapies that generate transformative results for people in the treatment of mental health conditions and a brand and share of voice that is reaching millions of people, Field Trip is a center of gravity for the psychedelic renaissance.

Learn more at, and

Follow us on Twitter and Instagram: @fieldtriphealth

To receive company updates about Field Trip and to be added to the email distribution list please sign up here.

Download Field Trip’s app here.

Cautionary Note Regarding Forward-Looking Information.

This release includes forward-looking information (within the meaning of Canadian securities laws) regarding the Company and its business. Often but not always, forward-looking information can be identified by the use of words such as "expect", "intends", "anticipated", "believes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would" or "will" be taken, occur or be achieved. Such statements are based on the current expectations and views of future events of the management of the Company and are based on assumptions and subject to risks and uncertainties. Although management believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. The forward-looking events and circumstances discussed in this release may not occur and could differ materially as a result of known and unknown risk factors and uncertainties affecting the companies, including sign-ups, downloads, engagement, reviews, ability of Field Trip to realize its business plan, grow its client base or app user base, use of the Field Trip application by users, uptake in existing or new programs by clinicians or patients, if any, acceptance of psychedelic treatments by clinicians, patients, and regulators, ability or effect of any clinical restructuring, future changes in regulatory regimes which govern Field Trip’s business, and/or the ability of Field Trip to realize on its business plan for broadened, holistic approach to mental health and wellbeing. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. Accordingly, readers should not place undue reliance on any forward-looking statements or information. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and the Company does not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise. Additional information relating to the Company, can be located on the SEDAR website at .

This press release does not constitute an offer to sell or the solicitation of an offer to buy securities.

Neither the TSX Venture Exchange nor its Regulation Services Provider, have approved the contents of this release or accept responsibility for the adequacy or accuracy of this release.


Field Trip Health & Wellness:
Ronan Levy
Chairman & CEO
(416) 505-0929

Media contacts:
Isabella Morreale
Autumn Communications
(862) 579-7944

Investor contacts:
Phil Carlson / Sophia Bashford
(646) 573-0776 / (929) 246-7307
KCSA Strategic Communications

SOURCE Field Trip Health & Wellness Ltd.

1 BMJ 2022;378:e067606,